The study of ALM-488 for intra-operative visualization of nerves in head and neck surgery

Alume Biosciences, Inc is starting a new clinical trial of ALM-488 for Intra-Operative Visualization of Nerves in Head and Neck Surgery.

This protocol describes prospective, open-label, blinded, randomized controlled, multicenter pivotal studies to evaluate ALM-488.

The clinical trial started in April 29, 2022 and will continue throughout October 1, 2023.

Length Measurement will be primary outcome measure. Nerve Length Measurement will be compared between WLR and WLR with FL Overlay.

For more details: https://ichgcp.net/clinical-trials-registry/NCT05377554.

Clinical Research News

Considerations for the Use of Real-World Data and Real-World Evidence To Support Regulatory Decision-Making for Drug and Biological Products
Submission of comments on ICH E6 (R3) Guideline for Good Clinical Practice(GCP) - Step 2b 
ICH E6(R3) Good Clinical Practice guidance - Step 2 Public Consultation
The study of the new investigational drug for acute myeloid leukemia and myelodysplastic syndrome
Open Label study of entrectinib in ROS1 gene fusion-positive rare adult, paediatric and teenage/young adult cancers
Gasherbrum Bio, Inc is starting the study of GSBR-1290 drug in overweight or obese healthy adults
A new study of Dexpramipexole in adolescents and adults with severe Eosinophilic Asthma

Kommende kliniske forsøg

The study of ALM-488 for intra-operative visualization of nerves in head and neck surgery

All jobs

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner